CompletedPhase NA

Effects of Prebiotics on GLP-1 in Type 2 Diabetes

Lead sponsor

Oslo University Hospital

Asset

GLP-1 / incretin class catch-all

Listed sites

Recruiting sites

Actual enrollment

Study population

Type 2 diabetes

Eligibility highlights

•BMI 18.5-40

Primary endpoint

•Changes in plasma GLP-1 in response to standardized test meal before

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT02569684

Org study ID1180 REK

Timeline

Milestones

Study first posted2015-10-07estimated

Last update posted2020-09-16actual

Study start2015-10actual (month precision)

Primary completion2018-01actual (month precision)

Study completion2019-12actual (month precision)

Assets

Investigational agents

GLP-1 / incretin class catch-all

Who this study enrolls

Type 2 diabetes

Who can enroll

Minimum age18 Years

SexAll

Healthy volunteersNot accepted

Inclusion criteria

•diabetes type 2

•BMI 18,5 - 40

•Not medicated with insulin, GLP-1 analogues or DPP4 inhibitors

•Moderate intake of alcohol

•Not excessive exercise

•Less than 3 kg weight change the last two months

•Intake of less than 30 g dietary fiber per day

Exclusion criteria

•IBD

•IBS

•Coeliac disease

•Have used antibiotics within the last two months

•Have used supplements with prebiotics or probiotics the last two months

•Pregnancy

Endpoints (1)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other (unclassified)

1 endpoint

Primary/protocol endpoint/low confidence

Changes in plasma GLP-1 in response to standardized test meal before and after six weeks of ingestion of prebiotic fibers or placebo

Time frame:six weeks

concentration, descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.